PF
Rating #134
Pfizer
Portfolio value
Stocks
Performance
1 Year
+25.69%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 95.35% of the portfolio
Adds
New Buys
Sold Outs
Cuts
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() ORIC | Pharmaceutical Pres | $8.07 | 0.00% | 5.38M | $43.98M | 18.60% 3.85ppt | 5.43% | 5 Quarters | Q4 2024 | |
2 ![]() ARVN | Pharmaceutical Pres | $19.17 | 0.00% | 3.46M | $41.01M | 17.34% 10.61ppt | 4.74% | 5 Quarters | Q4 2024 | |
3 ![]() CELC | Medical Laboratories | $13.09 | 0.00% | 349.41K | $34.85M | 14.74% 10.79ppt | 0.78% | 5 Quarters | Q4 2024 | |
4 ![]() WVE | Pharmaceutical Pres | $12.37 | 0.00% | 1.88M | $31.88M | 13.48% 10.34ppt | 1.12% | 5 Quarters | Q4 2024 | |
5 ![]() ALLO | Biological products | $2.13 | 0.00% | 22.03M | $30.18M | 12.76% 6.52ppt | 9.92% | 5 Quarters | Q4 2024 | |
6 ![]() ZURA | Biological products | $2.50 | 0.00% | 2.97M | $15.56M | 6.58% 3.64ppt | 3.14% | 5 Quarters | Q4 2024 | |
7 ![]() PYXS | Pharmaceutical Pres | $1.56 | 0.00% | 7.03M | $8.09M | 3.42% -0.15ppt | 11.24% | 5 Quarters | Q4 2024 | |
8 ![]() CRBU | Biological products | $1.59 | 0.00% | 4.69M | $7.46M | 3.15% 0.66ppt | 5.03% | 5 Quarters | Q4 2024 | |
9 ![]() CRDF | Biological products | $4.34 | 0.00% | 2.41M | $6.78M | 2.87% 1.73ppt | 3.61% | 5 Quarters | Q4 2024 | |
10 ![]() BHVN | Pharmaceutical Pres | $37.35 | 0.00% | 505.65K | $5.71M | 2.41% 0.68ppt | 0.48% | 5 Quarters | Q4 2024 | |
11 ![]() SPRO | Pharmaceutical Pres | $1.03 | 0.00% | 2.36M | $5.50M | 2.33% 1.31ppt | 4.20% | 5 Quarters | Q4 2024 | |
12 ![]() NXTC | Biotechnology | $5.86 | 0.00% | 157.65K | $2.24M | 0.95% 0.73ppt | 0.00% | 2 Quarters | Q3 2025 | |
13 ![]() ZNTL | Pharmaceutical Pres | $3.03 | 0.00% | 953.83K | $1.29M | 0.54% 0.22ppt | 1.32% | 5 Quarters | Q4 2024 | |
14 ![]() QTTB | Pharmaceutical Pres | $3.44 | 0.00% | 277.78K | $922.22K | 0.39% 0.26ppt | 2.27% | 5 Quarters | Q4 2024 | |
15 ![]() ANTX | Pharmaceutical Pres | $1.38 | 0.00% | 715.30K | $815.44K | 0.34% 0.14ppt | 2.36% | 5 Quarters | Q4 2024 | |
16 ![]() BOLT | Pharmaceutical Pres | $5.77 | 0.00% | 31.31K | $171.18K | 0.07% 0.03ppt | 1.63% | 3 Quarters | Q2 2025 | |
17 ![]() DNA | Biological products | $9.82 | 0.00% | 2.93K | $24.33K | 0.01% 0.00ppt | 0.01% | 5 Quarters | Q4 2024 | |
18 ![]() SENS | Industrial Instruments | $10.47 | Cut -95.00% | 2.17K | $11.98K | 0.01% 0.00ppt | 0.01% | 5 Quarters | Q4 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers